Search details
1.
Best Practice Guideline - DEGUM Recommendations on Breast Ultrasound. / Best Practice Guideline Empfehlungen der DEGUM zur Durchführung und Beurteilung der Mammasonografie.
Ultraschall Med
; 44(5): 520-536, 2023 Oct.
Article
in English, German
| MEDLINE | ID: mdl-37072031
2.
Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial.
Breast Cancer Res
; 24(1): 58, 2022 09 02.
Article
in English
| MEDLINE | ID: mdl-36056374
3.
Best Practice Guideline - DEGUM Recommendations on Breast Ultrasound. / Best Practice Guideline Empfehlungen der DEGUM zur Durchführung und Beurteilung der Mammasonografie TEIL I Untersuchungstechnik, Ultraschall-DEGUM-Kriterien und deren Dokumentation.
Ultraschall Med
; 43(6): 570-582, 2022 Dec.
Article
in English, German
| MEDLINE | ID: mdl-34921376
4.
Intraoperative central nipple biopsy in nipple-sparing mastectomy- A retrospective analysis of 211 patients.
Breast J
; 27(4): 363-368, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33619792
5.
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial.
Int J Cancer
; 146(1): 262-271, 2020 01 01.
Article
in English
| MEDLINE | ID: mdl-31162838
6.
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study.
BMC Cancer
; 19(1): 611, 2019 Jun 21.
Article
in English
| MEDLINE | ID: mdl-31227025
7.
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
Breast Cancer Res Treat
; 161(1): 63-72, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27798749
8.
Efficacy and safety of nab-paclitaxel 125 mg/m2 and nab-paclitaxel 150 mg/m2 compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69).
Breast Cancer Res Treat
; 163(3): 495-506, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28315068
9.
The Use of Acellular Dermal Matrices (ADM) in Breast Reconstruction: A Review.
Surg Technol Int
; 31: 53-60, 2017 Dec 22.
Article
in English
| MEDLINE | ID: mdl-29327777
10.
Nab-paclitaxel versus solvent-based paclitaxel in neoadjuvant chemotherapy for early breast cancer (GeparSepto-GBG 69): a randomised, phase 3 trial.
Lancet Oncol
; 17(3): 345-356, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26869049
11.
PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant.
Trials
; 24(1): 338, 2023 May 17.
Article
in English
| MEDLINE | ID: mdl-37198674
12.
Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer.
JAMA Surg
; 158(8): 807-815, 2023 08 01.
Article
in English
| MEDLINE | ID: mdl-37285140
13.
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial.
Clin Cancer Res
; 29(13): 2456-2465, 2023 07 05.
Article
in English
| MEDLINE | ID: mdl-37014668
14.
Mitomycin C in combination with vinorelbine in anthracycline- and/or taxane-pretreated patients with metastatic breast cancer.
Onkologie
; 35(9): 500-4, 2012.
Article
in English
| MEDLINE | ID: mdl-23007147
15.
Improving Breast Conserving Surgery Using the Faxitron® OR Specimen Radiography System - A Complication Analysis, Cost Evaluation and Literature Review.
Anticancer Res
; 42(4): 1925-1932, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35347012
16.
Evaluation of Real-world Data for Breast-MRI BI-RADS IV Lesions.
In Vivo
; 36(5): 2255-2259, 2022.
Article
in English
| MEDLINE | ID: mdl-36099097
17.
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast Cancer.
J Clin Oncol
; 40(23): 2557-2567, 2022 08 10.
Article
in English
| MEDLINE | ID: mdl-35404683
18.
De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial.
Clin Cancer Res
; 28(22): 4995-5003, 2022 11 14.
Article
in English
| MEDLINE | ID: mdl-35797219
19.
Benefits of early and prolonged fulvestrant treatment in 848 postmenopausal advanced breast cancer patients.
Breast Cancer Res Treat
; 125(1): 127-36, 2011 Jan.
Article
in English
| MEDLINE | ID: mdl-20960229
20.
Preoperative Octenidine Application in Breast Reconstruction Surgery.
In Vivo
; 35(1): 549-554, 2021.
Article
in English
| MEDLINE | ID: mdl-33402508